Skip to main content
DNA Labs India

PFN1 Gene Amyotrophic Lateral Sclerosis Type 18 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

PFN1 Gene Amyotrophic Lateral Sclerosis Type 18 NGS Genetic Test

Short Name: PFN1 ALS18 NGS

Also known as: PFN1 Gene Mutation Analysis, Profilin-1 Gene Sequencing, ALS18 Genetic Test, PFN1 ALS Type 18 NGS Panel

PFN1 Gene Amyotrophic Lateral Sclerosis Type 18 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) - targeted gene analysis on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are usually available within 3 to 4 weeks from sample receipt.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this NGS genetic test is to detect pathogenic and likely pathogenic variants in the PFN1 gene associated with amyotrophic lateral sclerosis type 18. It facilitates molecular confirmation of the diagnosis, helps assess the risk of disease in family members, and supports reproductive and clinical decisions in affected families.

Test Code
3888
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results are usually available within 3 to 4 weeks from sample receipt.
Fasting Required
No
Method
Next-Generation Sequencing (NGS) - targeted gene analysis
Step 1

Sample Collection

No fasting is required. Please complete the test request form, provide a valid doctor's referral if available, and attend the genetic counseling session. The counselor will draw a family pedigree to assess inheritance risk.

Method: Venous blood collection or FTA card spot

Step 2

Laboratory Analysis

For blood-based samples, a trained phlebotomist will collect blood into an EDTA tube under sterile conditions. For FTA cards, a few drops of blood will be spotted onto the card. The process is safe and takes only a few minutes.

Step 3

Report Delivery

The sample is labeled and transported to the laboratory. Genomic DNA is extracted and purified for next-generation sequencing. No post-procedure rest is required.

Timeline: Results are usually available within 3 to 4 weeks from sample receipt.

Patient Instructions

1
Before the Test:A genetic counseling session is recommended before testing. The counselor will explain the benefits, risks, and limitations. No fasting is required.
2
During the Test:A blood sample is collected in an EDTA vacutainer, or a spot of blood is taken on an FTA card. The procedure is quick and safe.
3
After the Test:The sample will be processed at the laboratory, followed by DNA extraction, NGS library preparation, sequencing, and clinical interpretation. The final report and raw data files are shared with the referring physician and patient.

About This Test

Who Should Get This Test

The purpose of this NGS genetic test is to detect pathogenic and likely pathogenic variants in the PFN1 gene associated with amyotrophic lateral sclerosis type 18. It facilitates molecular confirmation of the diagnosis, helps assess the risk of disease in family members, and supports reproductive and clinical decisions in affected families.

How to Prepare

  • No fasting required before sample collection.
  • Use an EDTA tube for whole blood collection.
  • If using an FTA card, apply one drop of blood to the card and allow it to air-dry completely.
  • Label the sample with the patient's name, unique ID, and date of collection.
  • Maintain the sample at room temperature during transport.
  • Ensure written informed consent is obtained before genetic testing.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Clinical correlation is essential in ALS. Genetic testing for PFN1 should be considered in familial or atypical presentations, alongside a neurologist-led evaluation."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeAs directed by laboratory protocol
ContainerEDTA Vacutainer / FTA Card / DNA Microfuge Tube
Collection MethodVenous blood collection or FTA card spot

Sample Stability

Whole Blood (EDTA)24-48 hours
Extracted DNALong-term stable
FTA CardStable for several days
Sample Rejection Criteria:
  • Clotted or hemolyzed blood sample
  • Insufficient sample volume
  • Unlabeled or mislabeled specimen
  • FTA card not properly dried or sealed
  • Sample with suspected contamination

Understanding Your Results

The PFN1 NGS genetic test result should be interpreted in the context of clinical symptoms, age of onset, family history, and other motor neuron disease genes. A genetic counselor or neurologist should review the report before any clinical decisions are made.
📊

Pathogenic variant detected

📊

Likely pathogenic variant detected

📊

Variant of uncertain significance (VUS)

📊

Benign or likely benign variant

📊

No pathogenic variant detected

⚠️ When to Consult a Doctor:

If you or a family member have muscle weakness, twitching, difficulty speaking or swallowing, or a known ALS family history, consult a neurologist to review clinical findings and decide whether PFN1 genetic testing is appropriate.

Limitations

  • Targeted PFN1 sequencing will not detect large structural rearrangements, deep intronic variants, or repeat expansions in other ALS genes.
  • A negative PFN1 result does not exclude ALS because mutations in other genes or non-genetic causes may be responsible.
  • A variant of uncertain significance may be reported and may require additional family segregation studies.
  • This test is not a whole-exome or whole-genome screen.

Risks & Considerations

  • No significant health risks are associated with this test.
  • Minor pain, bruising, or discomfort may occur at the blood collection site.
  • A genetic result may have emotional, social, or familial implications.

Interfering Factors

  • Insufficient or degraded DNA sample
  • Presence of PCR inhibitors in the extracted sample
  • Poor NGS coverage at PFN1 due to GC-rich regions or technical failure
  • Sample contamination during blood collection or processing
  • Incorrect or incomplete patient and family history information

Compare With Similar Tests

TestPFN1 Gene Amyotrophic Lateral Sclerosis Type 18 NGS Genetic TestPFN1 Gene TestSOD1 Gene TestC9orf72 Gene Test
ComparisonPFN1 Gene Amyotrophic Lateral Sclerosis Type 18 NGS Genetic Test

Frequently Asked Questions

What is the PFN1 Gene Amyotrophic Lateral Sclerosis Type 18 NGS Genetic Test?
It is a targeted next-generation sequencing test that looks for mutations in the PFN1 gene associated with ALS type 18, a rare inherited form of amyotrophic lateral sclerosis.
How much does this test cost in India?
At DNA Labs India, the PFN1 ALS18 NGS Genetic Test costs INR 20000, including free home sample collection.
What sample is needed for the PFN1 ALS18 genetic test?
The test can be performed on blood, extracted DNA, or one drop of blood spotted on an FTA card.
Do I need to fast before giving a sample?
No, fasting is not required for this genetic test.
How long does it take to get the report?
Reports are usually issued within 3 to 4 weeks after the sample reaches the laboratory.
What diseases are associated with the PFN1 gene?
Mutations in the PFN1 gene cause amyotrophic lateral sclerosis type 18, a rare autosomal dominant motor neuron disease.
Why is NGS used for this test?
NGS allows rapid and accurate sequencing of the PFN1 gene and can detect point mutations and small insertions or deletions with high sensitivity.
What should I do before booking this test?
A doctor's referral and written informed consent are recommended. A genetic counseling session is included to draw a family pedigree and discuss the implications of testing.
Can this test be used for predictive testing in an asymptomatic person?
Predictive testing should only be done after formal genetic counseling, in adult at-risk individuals, and preferably when the family's pathogenic PFN1 variant is already known.
What does a positive PFN1 result mean?
A positive result means a pathogenic or likely pathogenic PFN1 variant is detected. This supports the diagnosis of ALS type 18 and identifies a genetic cause in the family. Genetic counseling is advised.
What does a negative PFN1 result mean?
A negative result means no pathogenic PFN1 variant was identified. ALS could still be caused by variants in other genes or by non-genetic factors.
Does DNA Labs India provide raw data?
Yes. DNA Labs India provides raw data files, including FASTQ and VCF, along with the clinical report for full transparency and further interpretation.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.